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Australia is represented by the National Asthma Council.
The aims of the IPCRG are to provide an international network
for research in community settings, to guide and disseminate
evidence-based guidelines appropriate for primary care profession-
als (eg, GPs, nurses, pharmacists and healthcare workers), and to
provide practical resources for “respiratory professionals” in com-
munity settings around the world. Those involved in IPCRG
include such diverse groups as GPs, respiratory scientists, asthma
educators, pharmacists and physiotherapists.
The theme of the 2004 conference was “the way forward” in
managing respiratory disease in primary care. Major topics were
asthma, allergy and chronic obstructive pulmonary disease
(COPD), while tuberculosis, community-acquired pneumonia and
quality-of-life measurement also received substantial attention.
Topics were covered from the perspectives of clinical care, people
and public policy, and practical training, with plenary sessions,
workshops and submitted papers and posters.
Core issues arising
Proactive models of care should be developed and tested. Most
primary care respiratory management is reactive, and not organ-
ised or systematic. Different models of evidence-based proactive
care need to be developed and tested. New models presented at the
conference included telephone consultations for asthma review,
integrated decision support, nurse-led asthma clinics, practice-
based professional development programs linked to patient audits,
and community-based pharmacy outreach programs.
Guidelines need to be translated into daily practice. Several
internationally developed guidelines for asthma, COPD and rhini-
tis cannot be implemented in primary care (Professor Onno van
Schayck, Faculty of Medicine, University of Maastricht and Uni-
versity of Nijmegen, The Netherlands). Several plenary sessions
discussed how best to link guidelines to clinical practice in general
practice and other forms of primary care, including nurse-run
asthma clinics and Aboriginal community-controlled health serv-
ices. The “consensus” was that a model centred on the respiratory
complaints described by the patient at presentation is more
sustainable and may be more effective (eg, a model centred on
“cough” may be superior to one centred on “COPD”).
The link between allergy and asthma must be applied in clinical
practice. Evidence is emerging that effective management of
allergic rhinitis may ameliorate and prevent asthma (Associate
Professor Mini Tang, Head, Department of Immunology, Murdoch
Children’s Research Institute, Melbourne, and Dr Jacques Bou-
chard, St Joseph’s Hospital, La Malbaie, Quebec, Canada). As
almost 45% of the Australian population is atopic, and about a
third suffer allergic disease (Professor Robyn O’Hehir, Head of
Allergy and Respiratory Medicine, Alfred Hospital, and Monash
University, Melbourne, and the Cooperative Research Centre for
Asthma, Sydney), a number of speakers stressed the need to
consider allergy assessment in all patients with asthma.
Undiagnosed asthma and chronic obstructive pulmonary disease
must be identified more efficiently. Effective management is now
available for people with early signs of asthma and COPD and will
substantially improve their quality of life (Dr Christine Jenkins,
Director, Clinical Trials Unit, Woolcock Institute of Medical
Research, Royal Prince Alfred Hospital, Sydney).
More precise assessment of disease severity is needed. The
severity of asthma and COPD needs to be specified more precisely
to maximise the benefits and minimise the risks of interventions.
Smoking-cessation programs, appropriate use of inhaled cortico-
steroids and long-acting bronchodilators, pulmonary rehabilita-
tion, and self-management strategies all have a role, depending on
severity of the condition (Dr Christine Jenkins).
Major topics discussed
Asthma. With the recent release of the report on the global burden
of asthma,2 Professor Richard Beasley (Director, Medical Research
Institute of New Zealand, Wellington, New Zealand) highlighted
the increasing prevalence of asthma, particularly in Asia. He
maintained that the explanation is still uncertain, but multifacto-
rial, with environmental factors, increasing urbanisation and the
increasing prevalence of allergic disorders all implicated. This
suggests that addressing the increase in prevalence will require
multifaceted responses by clinicians, public health physicians,
consumers, industry and governments (eg, by providing all essen-
tial drugs to treat people with asthma in all Asia-Pacific countries).
He argued that primary care is a substantial part of the solution
and has specific challenges, including development of simple
algorithms for patients who present with vague symptoms of
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dose of inhaled corticosteroid is used to control symptoms. Some
newly recognised side effects include dental and vision problems.
Up to 45% of people taking moderate amounts of inhaled
corticosteroids report some side effects (Professor Thys Van der
Molen, Department of General Practice, University of Groningen,
The Netherlands). Van der Molen commented that primary-care
clinicians often do not have the time or tools to identify these less
well known side effects.
Severe acute respiratory syndrome. Associate Professor Cheong
Pak Yean (Family Physician, Faculty of Medicine, National Univer-
sity of Singapore) described Singapore’s response to the epidemic
of severe acute respiratory syndrome (SARS). The strategy involved
detecting, isolating and “ring-fencing” the virus at four levels —
the border, hospital, community, and primary care. Border defence
involved screening travellers for possible SARS as they entered
Singapore. The hospital defence involved managing all people with
SARS (or possible SARS) in hospital, with use of personal protec-
tive equipment by staff (masks, gloves, gowns, and goggles) plus
barrier nursing in single-patient isolation rooms. Community
defences included mass education, twice-daily temperature meas-
urement for any suspected cases, and closure of “at-risk” gather-
ings, such as markets. In primary care, strategies used included GP
education campaigns, telephone information hotlines, and “fever
and evacuation” rooms in GP surgeries (separate rooms for patients
with suspected SARS awaiting evacuation to hospital).
Chronic obstructive pulmonary disease. Identifying people with
early smoking-related lung damage would seem a major task. The
number of people with COPD in Australia will increase significantly
over the next 10–15 years; the estimated prevalence may well exceed
300000 cases (Professor Justin Beilby, Department of General Prac-
tice, University of Adelaide, SA), and the total number of COPD
sufferers (both diagnosed and undiagnosed) could range from
620000 to 2.6 million cases.3 A GP-friendly algorithm based on the
recently completed COPDX guidelines4 was presented. Fitting on
two A4 pages, this has since been refined and released (Box).
Symptom-based questionnaires. There was much discussion
about GPs identifying specific conditions, such as undiagnosed
COPD. Professor David Price (General Practice Airways Group,
Professor of Primary Care Respiratory Medicine, University of
Aberdeen, UK) reported on a study of the link between symptoms
and results of spirometry testing in 417 current or former smokers
recruited from primary-care practices in the United Kingdom and
the United States. Predictors were identified that may be useful in
identifying early COPD, as measured by spirometry, including:
• Age group (in years).
• Pack-years smoked (How many cigarettes do you currently smoke
each day [if you are an ex-smoker, how many did you smoke each day]?
What is the total number of years you have smoked cigarettes?).
• Recent cough (Have you coughed more in the past few years?).
• Breathing-related work loss (During the past 3 years, have you
had any breathing problems that have kept you off work, indoors, at
home, or in bed?).
• Hospitalisation for breathing problems (Have you ever been
admitted to hospital with breathing problems?).
• Recent breathlessness (Have you been short of breath more often in
the past few years?).
• Cold usually goes to the chest (If you get a cold, does it usually go
to your chest?).
It was agreed that these questions require validation among
other communities before they can be used as predictors in
everyday clinical practice.
Conclusion
This was the second IPCRG conference, the first being held in
Amsterdam in 2002. The developing international IPCRG net-
works have now begun developing innovative research programs,
such as further validation of the symptom-based questionnaires
discussed above. These programs will become the platform for the
next conference, to be held in Oslo in 2006. The IPCRG research
subcommittee has begun developing a strategic plan for the group
— a challenge, because of the diversity of the member countries
and the variable access to resources and research expertise across
the group. However, meeting the challenge through sharing
expertise and skills may also be a great opportunity for IPCRG.
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Main steps of COPDX checklist for diagnosis and 
management of chronic obstructive pulmonary disease5
C – Confirm diagnosis
Presence and history of symptoms
Smoking – history and willingness to quit
Spirometry – measure FEV1 and FEV1/FVC and assess 
reversibility of airflow limitation
O – Optimise function
Including check of smoking status, optimal therapy and exercise 
status
P – Prevent deterioration
Essential steps (including pneumococcal and annual influenza
vaccination)
Risk-factor reduction (including help with smoking cessation)
D – Develop self-management plan
Including referral for pulmonary rehabilitation or to respiratory 
physician or hospital, if appropriate
X – Manage eXacerbations
Including ensuring understanding of importance of early
treatment for exacerbations; regular review68 MJA • Volume 181 Number 2 • 19 July 2004
